ENTX stock jumps 35% in a month after the FDA backs a streamlined phase III plan for oral osteoporos

Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session

Entera Bio (NASDAQ:ENTX) may have just cleared its biggest regulatory hurdle yet. The FDA has provid

Entera Bio (NASDAQ: ENTX) may have just cleared its biggest regulatory hurdle yet. The FDA has provi

Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market sessi

Gainers Catheter Precision (AMEX:VTAK) shares rose 78.2% to $1.55 during Monday's after-market

Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 79.6% to $0.63 during Monday's regul

Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the developm

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primar

EB612, a first-in-class long-acting PTH(1-34) oral peptide  for hypoparathyroidism, produced robust

EB612, a first-in-class long-acting PTH(1-34) oral peptide  for hypoparathyroidism, produced robust

The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB61

TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteopor

Entera Bio (ENTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the

Entera Bio Ltd. (ENTX) Discusses Osteoporosis Treatment Landscape and Clinical Potential of EB613 Or

In a virtual Key Opinion Leader (KOL) roundtable hosted today, Entera Bio (Nasdaq: ENTX) convened gl

TEL AVIV, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- TEL AVIV, Israel, April 14, 2026 -- Entera Bio

MIAMI, April 6, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised Israel-based En

TEL AVIV, Israel, April 02, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX) (“Entera” or the

Editor's Note: The future prices of benchmark tracking ETFs and the headline were updated in the sto

Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the sto

U.S. stock futures rose on Monday following Friday's sharp sell-off. Futures of the major benchmark

U.S. stock futures up, focus on quarterly earnings of Americas Gold and Silver, ARKO Petroleum, Ente

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteopor

Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24

Entera Bio Ltd. shares jumped 15.71% in after-hours trading following a director's purchase of addit

TEL AVIV, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company

New Chairman Joins Entera's Board with Senior Global Leadership Experience from Pfizer, Wyeth and Ot

This is the third program that successfully combines Entera's oral peptide N-Tab® platform with

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday afte

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12

  During Wednesday's trading, 517 companies set new 52-week lows.

  During Monday's session, 402 companies made new 52-week lows.

  On Thursday, 930 stocks hit new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.